Status:
COMPLETED
The Effects of Added Enzyme α-Galactosidase at a Carbohydrate-rich Meal in Irritable Bowel Syndrome (IBS)
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-70 years
Phase:
EARLY_PHASE1
Brief Summary
IBS (irritable bowel syndrome) is a functional gastrointestinal disorder which is characterized by recurrent pain and/or discomfort, altered stool form, and abdominal distension. It has been establish...
Eligibility Criteria
Inclusion
- Patients diagnosed with Irritable Bowel Syndrome(IBS), (in accordance with ROME III criteria), and
- With the specific symptoms of bloating and/or abdominal distension.
Exclusion
- The patients should not have any other gastrointestinal diseases such as IBD or celiac disease.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01483287
Start Date
November 1 2011
End Date
August 1 2013
Last Update
November 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska University Hospital
Gothenburg, Sweden, 41139